Literature DB >> 18958263

Permanent cardiac pacing for neurocardiogenic syncope.

J H Ruiter1, M Barrett.   

Abstract

Vasovagal syncope is not a benign condition in the elderly population. In patients not responsive to conservative therapy and whose abrupt faints are associated with serious injuries and seriously affected quality of life, pacemaker therapy was suggested. However, the usefulness of cardiac pacing for the prevention of recurrences of vasovagal syncope remains controversial because of the dominant role of the vasodepressor component during the episode. In the Medical Center Alkmaar, the Head-Up Tilt Test (HUTT) has been used since 1996 during the work-up of patients who present with vasovagal syncope. The HUTT showed a dominant cardioinhibitory response in 4.5% of our patients; in elderly patients with vasovagal syncope without prodromal symptoms and refractory on conservative therapy, pacemaker therapy was very effective in preventing syncope during long-term follow-up. (Neth Heart J 2008;16(Suppl1):S15-S19.).

Entities:  

Keywords:  cardiac; pacing; syncope; vasovagal

Year:  2008        PMID: 18958263      PMCID: PMC2572013     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  14 in total

Review 1.  Syncope, cerebral perfusion, and oxygenation.

Authors:  Johannes J Van Lieshout; Wouter Wieling; John M Karemaker; Niels H Secher
Journal:  J Appl Physiol (1985)       Date:  2003-03

2.  Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing.

Authors:  C T Paul Krediet; Nynke van Dijk; Mark Linzer; Johannes J van Lieshout; Wouter Wieling
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

3.  Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary.

Authors:  Michele Brignole; Paolo Alboni; David G Benditt; Lennart Bergfeldt; Jean-Jacques Blanc; Poul Erik Bloch Thomsen; J Gert van Dijk; Adam Fitzpatrick; Stefan Hohnloser; Jan Janousek; Wishwa Kapoor; Rose Anne Kenny; Piotr Kulakowski; Giulio Masotti; Angel Moya; Antonio Raviele; Richard Sutton; George Theodorakis; Andrea Ungar; Wouter Wieling; Silvia G Priori; Maria Angeles Alonso Garcia; Andrzej Budaj; Martin Cowie; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindhal; Gianfranco Mazzotta; João Morais; Ali Oto; Otto Smiseth; Carlo Menozzi; Hugo Ector; Panos Vardas
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

4.  AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society.

Authors:  S Adam Strickberger; D Woodrow Benson; Italo Biaggioni; David J Callans; Mitchell I Cohen; Kenneth A Ellenbogen; Andrew E Epstein; Paul Friedman; Jeffrey Goldberger; Paul A Heidenreich; George J Klein; Bradley P Knight; Carlos A Morillo; Robert J Myerburg; Cathy A Sila
Journal:  Circulation       Date:  2006-01-17       Impact factor: 29.690

5.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.

Authors:  S J Connolly; R Sheldon; R S Roberts; M Gent
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

6.  Diagnostic value of history in patients with syncope with or without heart disease.

Authors:  P Alboni; M Brignole; C Menozzi; A Raviele; A Del Rosso; M Dinelli; A Solano; N Bottoni
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

7.  Observations on recurrent syncope and presyncope in 641 patients.

Authors:  C J Mathias; K Deguchi; I Schatz
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

8.  Vasovagal syncope interrupting sleep?

Authors:  C T P Krediet; D L Jardine; P Cortelli; A G R Visman; W Wieling
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

9.  Permanent cardiac pacing for neurocardiogenic syncope.

Authors:  J H Ruiter; M Barrett
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

10.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.

Authors:  Stuart J Connolly; Robert Sheldon; Kevin E Thorpe; Robin S Roberts; Kenneth A Ellenbogen; Bruce L Wilkoff; Carlos Morillo; Michael Gent
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

View more
  1 in total

1.  Permanent cardiac pacing for neurocardiogenic syncope.

Authors:  J H Ruiter; M Barrett
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.